Continuous IOP Monitoring: A Breakthrough in Glaucoma Management

Eye pressure tends to be most elevated in the early morning when patients are asleep. These unmonitored early morning spikes can negatively affect glaucoma management. While home monitoring devices are helpful, their effectiveness depends on users taking the initiative to take a measurement.

Tonoptic is a minimally invasive, implantable device created to offer continuous eye pressure monitoring, enabling personalized and precise glaucoma management.

Utilizing advanced microelectronics, Tonoptic will feature an optically integrated MEMS pressure sensor and a handheld reader. The device will integrate with the Twenty/Twenty Vision Suite for comprehensive glaucoma management.

Tonoptic is set to revolutionize glaucoma care.

*Note: These products in development have not been evaluated by FDA, and are not available for sale in the United States.